Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases
Kataoka, K, et al. JAMA Oncology, 2026
Read More
Oncology
Resources related to tests that help detect circulating tumor DNA for molecular residual disease assessment.
-
-
Redefining HNSCC Management with Signatera™ MRD Testing: A Multidisciplinary Perspective
Watch Video
-
My patient is Signatera-positive. Now What?
Watch Video
-
Molecular Residual Disease (MRD) Testing: Advancing Clinical Decision-Making in Breast Cancer
Read More
-
MRD Insights for Radiation Oncology in NSCLC
Watch Video
-
Latitude One Pager
Read More
-
Anal One Pager
Read More
-
HCC One Pager
Read More
-
MDT+TOMR One Pager
Read More
-
Gastroesophageal One Pager
Read More
-
Pancreas One Pager
Read More
-
From Clinical Insight to Trial Design: Advancing Circulating Tumor DNA-Informed Care in Pancreatic Cancer
Ascherman B, King D. J Gastrointest Oncol 2026
Read More
-
Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer a randomized phase 3 trial
Bando et al. Nature, 2026
Read More
-
ASBrS 2026: Optimizing Breast Cancer
Leading Breast Surgeons Discuss MRD Testing
Watch Video
-
When Sample Type Matters: The Utilization of Fibroblast Testing in Hereditary Cancer
Watch Video
-
Cell Culturing for Skin Fibroblast Testing Requisition Form
Read More
-
Fibroblast Ordering Guide
Read More
-
Fibroblast Brochure
Read More
-
Altera™ Brochure
Read More
-
Driving clinical development with real-world molecular intelligence
Watch Video
-
Loading More...
